On May 8, 2019 Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer, autoimmune disease, asthma and allergic diseases, reported that company management will present at two upcoming conferences (Press release, Xencor, MAY 8, 2019, View Source [SID1234535955]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Bank of America Merrill Lynch 2019 Health Care Conference
Date: Wednesday, May 15, 2019
Location: Las Vegas, NV
Presentation Time: 4:20 p.m. PT
Berenberg Conference USA 2019
Date: Wednesday, May 22, 2019
Location: Tarrytown, NY
Presentation Time: 9:45 a.m. ET
A live webcast of the Bank of America Merrill Lynch conference will be available under "Events & Presentations" in the Investors section of the Company’s website located at View Source A replay of the event will be posted on the Xencor website approximately one hour after the live event and will be available for 90 days following the event.